And increased MMP-2 activity can in turn promote ECM degradation, which also contributes to the reversal of renal interstitial fibrosis [7,8] Therefore, this study further supports the viewpoint that Src is a promising target for the treatment of renal fibrosis. Here, MMP2 is linked to renal fibrosis.